ONCOLOGY[18F]FDG PET is a common assay of glycolysis for use in oncology. Thanks to its high sensitivity, GENISYS4 can detect changes in tumor glycolysis with [18F]FDG to differentiate malignant tissue from necrosis and edema.
Measuring Drug Resistance
CELL THERAPYGene and cell-based therapies are creating
new opportunities in oncology research.
Scientists are able to use PET, along with
optical techniques, for in vivo detection of
reporter gene-labelled transplanted cells.
CARDIOLOGY[18F]FDG PET can provide important insights into the physiology and biology of the heart and enable researchers to explore the effects of new therapeutics.
BIODISTRIBUTIONGENISYS4 is capable of performing dynamic studies to measure the kinetics of transport and metabolism. In the end, it’s not just about images, but about quantitative measurements of kinetics.